NEUTROPHASE— 510(k) K081009

Substantially Equivalent

Novabay Pharmaceuticals

FDA 510(k) clearance K081009 for NEUTROPHASE, Substantially Equivalent on 2008-05-20. Applicant: Novabay Pharmaceuticals.

Clearance details

Applicant: Novabay Pharmaceuticals
Product code: Code KMF
Advisory panel: General Hospital
Date received: 2008-04-08
Decision date: 2008-05-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Emeryville, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.